Group 1 - The company, Zhenhua New Materials, announced the appointment of Zhou Chaoyi as the vice president, effective from the date of the board meeting on October 24, 2025, until the end of the current board's term [1] - The revenue composition for Zhenhua New Materials in 2024 is reported to be 98.19% from cathode materials and 1.81% from other businesses [1] - As of the report date, Zhenhua New Materials has a market capitalization of 7.2 billion yuan [1] Group 2 - The article highlights that the Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a robust market for biopharmaceuticals [1] - There is a contrast noted between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [1]
振华新材:聘任周朝毅担任公司副总经理